fda warning bpc-157 not approved human use peptide unapproved new drug The FDA has issued clear signals on BPC-157 Regeneration or Risk? A Narrative
Description
doesnt raise IGF-1 or disrupt glucose regulation

[PubMed: 40756949] The pattern across the research is consistent: BPC-157 appears to support healing through multiple overlapping pathways, with a strong safety signal
Patients should seek urgent medical advice if they develop neurological symptoms, as these may require immediate treatment with intramuscular hydroxocobalamin

Cardiovascular manifestations of intermediate and major hyperhomocysteinemia due to vitamin B12 and folate deficiency and/or inherited disorders of one-carbon metabolism: a 3.5-year retrospective cross-sectional study of consecutive patients
